1 Min Read
(Reuters) - Valeant Pharmaceuticals International (VRX.TO) is near a deal to buy Salix Pharmaceuticals Ltd SLXP.O for about $10 billion, the Wall Street Journal reported on Saturday.
Reporting by Eric Beech
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.